- II-VI Inc IIVI reported fourth-quarter FY21 revenue growth of 8.3% year-on-year to $808 million, beating the analyst consensus of $783.33 million.
- Segments: Photonic Solutions revenue increased 6.3% Y/Y to $549.7 million. Revenue from Compound Semiconductors rose 12.8% Y/Y to $258.3 million.
- Margins: The non-GAAP gross margin contracted 370 bps to 38.6% as the costs rose 12.7% Y/Y.
- The non-GAAP operating margin expanded 170 bps to 18.4% as the expenses declined 18% Y/Y.
- Non-GAAP operating margin for Compound Semiconductors expanded 810 bps to 23.7%, while contracted 130 bps to 15.9% for Photonic Solutions segment.
- Non-GAAP EPS of $0.88 beat the analyst consensus of $0.76.
- II-VI held $1.6 billion in cash and equivalents as of June 30, 2021, and generated $574.4 million in operating cash flow during FY21.
- The Q4 revenue exceeded the top end of II-VI's guidance with a book-to-bill ratio of 1.14.
- In communications, FY21 revenue improved 11%, driven by 100, 200, 400G datacom transceivers and coherent optics.
- II-VI's life sciences revenue grew by 65% Y/Y in support of COVID and other diagnostic testing.
- II-VI expects the pending acquisition of Coherent Inc COHR to close during the first calendar quarter of 2022.
- Outlook: II-VI sees Q1 FY22 revenue of $780 million - $830 million compared to the analyst consensus of $804.04 million.
- It forecasts a non-GAAP EPS of $0.75 - $0.90 versus the analyst consensus of $0.90.
- Price action: IIVI shares traded lower by 5.30% at $64.26 on the last check Tuesday.
Loading...
Loading...
COHRCoherent Corp
$71.984.06%
Edge Rankings
Momentum
37.17
Growth
-
Quality
85.41
Value
14.53
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
